MAPT and Alzheimer disease: The paper further explored the biomarkers' utility in disease diagnosis and drug target development.<h4>Results</h4>Research on biomarkers mainly focused on amyloid-β (Aβ) plaques, Tau protein abnormal phosphorylation, axon damage, synaptic dysfunction, inflammation, and related hypotheses associated with AD mechanisms.